These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24451644)

  • 1. Small molecule inhibitors of the HIV-1 virulence factor, Nef.
    Smithgall TE; Thomas G
    Drug Discov Today Technol; 2013 Dec; 10(4):e523-9. PubMed ID: 24451644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure, function, and inhibitor targeting of HIV-1 Nef-effector kinase complexes.
    Staudt RP; Alvarado JJ; Emert-Sedlak LA; Shi H; Shu ST; Wales TE; Engen JR; Smithgall TE
    J Biol Chem; 2020 Oct; 295(44):15158-15171. PubMed ID: 32862141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral Drug Discovery Targeting the HIV-1 Nef Virulence Factor.
    Emert-Sedlak LA; Shi H; Tice CM; Chen L; Alvarado JJ; Shu ST; Du S; Thomas CE; Wrobel JE; Reitz AB; Smithgall TE
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Contribution of Extracellular Nef to HIV-Induced Pathogenesis.
    Olivetta E; Arenaccio C; Manfredi F; Anticoli S; Federico M
    Curr Drug Targets; 2016; 17(1):46-53. PubMed ID: 26424397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effector kinase coupling enables high-throughput screens for direct HIV-1 Nef antagonists with antiretroviral activity.
    Emert-Sedlak LA; Narute P; Shu ST; Poe JA; Shi H; Yanamala N; Alvarado JJ; Lazo JS; Yeh JI; Johnston PA; Smithgall TE
    Chem Biol; 2013 Jan; 20(1):82-91. PubMed ID: 23352142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research Progress of HIV-1 Nef Inhibitors.
    Lv Y; Meng Y; Zhong J; Wan J; Zou W
    AIDS Rev; 2020 Oct; 22(4):221-226. PubMed ID: 33105470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-I Nef inhibitors: a novel class of HIV-specific immune adjuvants in support of a cure.
    Dekaban GA; Dikeakos JD
    AIDS Res Ther; 2017 Sep; 14(1):53. PubMed ID: 28893294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tight-Binding Hydroxypyrazole HIV-1 Nef Inhibitors Suppress Viral Replication in Donor Mononuclear Cells and Reverse Nef-Mediated MHC-I Downregulation.
    Shi H; Tice CM; Emert-Sedlak L; Chen L; Li WF; Carlsen M; Wrobel JE; Reitz AB; Smithgall TE
    ACS Infect Dis; 2020 Feb; 6(2):302-312. PubMed ID: 31775511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtle Dynamic Changes Accompany Hck Activation by HIV-1 Nef and are Reversed by an Antiretroviral Kinase Inhibitor.
    Wales TE; Hochrein JM; Morgan CR; Emert-Sedlak LA; Smithgall TE; Engen JR
    Biochemistry; 2015 Oct; 54(41):6382-91. PubMed ID: 26440750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of HIV-1 Nef: applications and developments for a practical cure.
    Lurie A; Fink C; Gosselin G; Dekaban GA; Dikeakos JD
    Virologie (Montrouge); 2022 Jan; 26(1):17-33. PubMed ID: 35766095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 Nef-Induced Secretion of the Proinflammatory Protease TACE into Extracellular Vesicles Is Mediated by Raf-1 and Can Be Suppressed by Clinical Protein Kinase Inhibitors.
    Zhao Z; Fagerlund R; Baur AS; Saksela K
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33597213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for inhibiting function of HIV-1 accessory proteins: a necessary route to AIDS therapy?
    Richter SN; Frasson I; Palù G
    Curr Med Chem; 2009; 16(3):267-86. PubMed ID: 19149577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Binding Mode and Prospective Structural Features of Novel Nef Protein Inhibitors as Potential Anti-HIV Drugs.
    Moonsamy S; Bhakat S; Ramesh M; Soliman ME
    Cell Biochem Biophys; 2017 Mar; 75(1):49-64. PubMed ID: 27981421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of orally active small molecule HIV-1 Nef antagonists.
    Emert-Sedlak LA; Loughran HM; Shi H; Kulp JL; Shu ST; Zhao J; Day BW; Wrobel JE; Reitz AB; Smithgall TE
    Bioorg Med Chem Lett; 2016 Mar; 26(5):1480-1484. PubMed ID: 26852364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical library screens targeting an HIV-1 accessory factor/host cell kinase complex identify novel antiretroviral compounds.
    Emert-Sedlak L; Kodama T; Lerner EC; Dai W; Foster C; Day BW; Lazo JS; Smithgall TE
    ACS Chem Biol; 2009 Nov; 4(11):939-47. PubMed ID: 19807124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A specific protein disorder catalyzer of HIV-1 Nef.
    Lugari A; Breuer S; Coursindel T; Opi S; Restouin A; Shi X; Nazabal A; Torbett BE; Martinez J; Collette Y; Parrot I; Arold ST; Morelli X
    Bioorg Med Chem; 2011 Dec; 19(24):7401-6. PubMed ID: 22061824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viremic long-term nonprogressive HIV-1 infection is not associated with abnormalities in known Nef functions.
    Heigele A; Camerini D; van't Wout AB; Kirchhoff F
    Retrovirology; 2014 Feb; 11():13. PubMed ID: 24495362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The accessory factor Nef links HIV-1 to Tec/Btk kinases in an Src homology 3 domain-dependent manner.
    Tarafdar S; Poe JA; Smithgall TE
    J Biol Chem; 2014 May; 289(22):15718-28. PubMed ID: 24722985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular Cytotoxicity.
    Alsahafi N; Ding S; Richard J; Markle T; Brassard N; Walker B; Lewis GK; Kaufmann DE; Brockman MA; Finzi A
    J Virol; 2015 Dec; 90(6):2993-3002. PubMed ID: 26719277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity analysis of diphenylpyrazolodiazene inhibitors of the HIV-1 Nef virulence factor.
    Iyer PC; Zhao J; Emert-Sedlak LA; Moore KK; Smithgall TE; Day BW
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1702-6. PubMed ID: 24650642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.